These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18819123)

  • 1. High risk neuroblastoma: a persistent therapeutic challenge.
    Garaventa A; Perilongo G
    Pediatr Blood Cancer; 2008 Dec; 51(6):722-3. PubMed ID: 18819123
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Seeger RC
    Prog Clin Biol Res; 1994; 385():287-91. PubMed ID: 7972222
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of neuroblastoma using autologous peripheral blood stem cells.
    Girard A; Le Brun E; Troussard X; Batho A
    Prog Clin Biol Res; 1990; 337():75-7. PubMed ID: 1972287
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-dose chemotherapy and hematopoietic stem cell transplant in the treatment of advanced neuroblastoma].
    Mugishima H
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1056-67. PubMed ID: 10431577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroblastoma trial to overcome a rare malignant disease].
    Fukushima T; Shichino H; Kumagai M
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):167-74. PubMed ID: 17301522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of stage IV neuroblastoma treated with aggressive surgery following intensive neoadjuvant chemotherapy with autologous stem cell transplantation.
    Yamamoto Y; Makimoto A
    Jpn J Clin Oncol; 2012 Apr; 42(4):359. PubMed ID: 22457363
    [No Abstract]   [Full Text] [Related]  

  • 7. A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapy.
    Hashii Y; Kusafuka T; Ohta H; Yoneda A; Osugi Y; Kobayashi Y; Fukuzawa M; Hara J
    Pediatr Hematol Oncol; 2008 Jun; 25(5):439-50. PubMed ID: 18569846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safer regimen for high-risk neuroblastoma.
    Felix CA
    Pediatr Blood Cancer; 2009 Jul; 53(1):3-6. PubMed ID: 19431215
    [No Abstract]   [Full Text] [Related]  

  • 9. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
    Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
    J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
    J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroblastoma. Therapeutic considerations].
    Sánchez de Toledo Codina J; Prats Villas J
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():81-4. PubMed ID: 6660675
    [No Abstract]   [Full Text] [Related]  

  • 12. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
    Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
    Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics therapy in AML.
    Radich GP
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
    [No Abstract]   [Full Text] [Related]  

  • 14. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High dosage chemotherapy and stem cell transplantation: the degree of responsibility must not be underestimated].
    Wiszniewsky G; Janke K
    Pflege Z; 2005 Nov; 58(11):692-5. PubMed ID: 16329694
    [No Abstract]   [Full Text] [Related]  

  • 17. Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?
    Cazzola M
    Nat Clin Pract Oncol; 2004 Nov; 1(1):22-3. PubMed ID: 16264794
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience.
    Agarwal R; Dvorak CC; Stockerl-Goldstein KE; Johnston L; Srinivas S
    Bone Marrow Transplant; 2009 Apr; 43(7):547-52. PubMed ID: 18997833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction for high-risk neuroblastoma.
    Kushner BH; Cheung NK
    Pediatr Blood Cancer; 2007 Sep; 49(3):221-3. PubMed ID: 17417798
    [No Abstract]   [Full Text] [Related]  

  • 20. Event-free survival of patients with high-risk neuroblastoma treated with an N6-like induction treatment.
    Valteau-Couanet D
    J Clin Oncol; 2005 Sep; 23(25):6262-3; author reply 6263. PubMed ID: 16135497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.